1
|
Darwish DG, El-Sherief HAM, Abdel-Aziz SA, Abuo-Rahma GEDA. A decade's overview of 2-aminothiophenes and their fused analogs as promising anticancer agents. Arch Pharm (Weinheim) 2024; 357:e2300758. [PMID: 38442316 DOI: 10.1002/ardp.202300758] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2023] [Revised: 02/05/2024] [Accepted: 02/07/2024] [Indexed: 03/07/2024]
Abstract
Over the past decades, cancer has been a challenging domain for medicinal chemists as it is an international health concern. In association, small molecules such as 2-aminothiophenes and their derivatives showed significant antitumor activity through variable modes of action. Therefore, this article aims to review the advances regarding these core scaffolds over the past 10 years, where 2-aminothiophenes and their fused analogs are classified and discussed according to their biological activity and mode of action, in the interest of boosting new design pathways for medicinal chemists to develop targeted antitumor candidates.
Collapse
Affiliation(s)
- Donia G Darwish
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Deraya University, New Minia, Minia, Egypt
| | - Hany A M El-Sherief
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Deraya University, New Minia, Minia, Egypt
| | - Salah A Abdel-Aziz
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Deraya University, New Minia, Minia, Egypt
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut, Egypt
| | - Gamal El-Din A Abuo-Rahma
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Deraya University, New Minia, Minia, Egypt
- Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, Minia, Egypt
| |
Collapse
|
2
|
Oliveira VDS, Silva CC, de Freitas Oliveira JW, da Silva MDS, Ferreira PG, da Siva FDC, Ferreira VF, Barbosa EG, Barbosa CG, Moraes CB, Freitas-Junior LHGD, Converti A, Lima ÁAND. The evaluation of in vitro antichagasic and anti-SARS-CoV-2 potential of inclusion complexes of β- and methyl-β-cyclodextrin with naphthoquinone. J Drug Deliv Sci Technol 2023; 81:104229. [PMID: 36776572 PMCID: PMC9905044 DOI: 10.1016/j.jddst.2023.104229] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2022] [Revised: 01/19/2023] [Accepted: 02/01/2023] [Indexed: 02/10/2023]
Abstract
The compound 3a,10b-dihydro-1H-cyclopenta[b]naphtho[2,3-d]furan-5,10-dione (IVS320) is a naphthoquinone with antifungal and antichagasic potential, which however has low aqueous solubility. To increase bioavailability, inclusion complexes with β-cyclodextrin (βCD) and methyl-β-cyclodextrin (MβCD) were prepared by physical mixture (PM), kneading (KN) and rotary evaporation (RE), and their in vitro anti-SARS-CoV-2 and antichagasic potential was assessed. The formation of inclusion complexes led to a change in the physicochemical characteristics compared to IVS320 alone as well as a decrease in crystallinity degree that reached 74.44% for the IVS320-MβCD one prepared by RE. The IVS320 and IVS320-MβCD/RE system exhibited anti-SARS-CoV-2 activity, showing half maximal effective concentrations (EC50) of 0.47 and 1.22 μg/mL, respectively. Molecular docking simulation suggested IVS320 ability to interact with the SARS-CoV-2 viral protein. Finally, the highest antichagasic activity, expressed as percentage of Tripanosoma cruzi growth inhibition, was observed with IVS320-βCD/KN (70%) and IVS320-MβCD/PM (72%), while IVS320 alone exhibited only approximately 48% inhibition at the highest concentration (100 μg/mL).
Collapse
Affiliation(s)
- Verônica da Silva Oliveira
- Department of Pharmacy, Health Sciences Center, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, 59012-570, Brazil
| | - Cláudia Cândida Silva
- School of Technology, State University of Amazonas, Manaus, Amazonas, 69065-020, Brazil
| | - Johny Wysllas de Freitas Oliveira
- Department of Pharmacy, Health Sciences Center, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, 59012-570, Brazil
| | - Marcelo de Sousa da Silva
- Department of Pharmacy, Health Sciences Center, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, 59012-570, Brazil
- Global Health and Tropical Medicine, Institute of Hygiene and Tropical Medicine, NOVA University Lisbon, Lisbon, 1800-166, Portugal
| | - Patricia Garcia Ferreira
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Fluminense Federal University, Niterói, Rio de Janeiro, 24241-002, Brazil
| | | | - Vitor Francisco Ferreira
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Fluminense Federal University, Niterói, Rio de Janeiro, 24241-002, Brazil
| | - Euzébio Guimarães Barbosa
- Department of Pharmacy, Health Sciences Center, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, 59012-570, Brazil
| | - Cecília Gomes Barbosa
- Department of Microbiology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, São Paulo, 05508-900, Brazil
| | - Carolina Borsoi Moraes
- Department of Microbiology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, São Paulo, 05508-900, Brazil
- Department of Pharmaceutical Sciences, Federal University of São Paulo, São Paulo, São Paulo, 09913-030, Brazil
| | | | - Attilio Converti
- Department of Civil, Chemical and Environmental Engineering, University of Genoa, Pole of Chemical Engineering, via Opera Pia 15, 16145, Genoa, Italy
| | - Ádley Antonini Neves de Lima
- Department of Pharmacy, Health Sciences Center, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, 59012-570, Brazil
| |
Collapse
|
3
|
Oliveira VDS, da Cruz MM, Bezerra GS, Silva NESE, Nogueira FHA, Chaves GM, Sobrinho JLS, Mendonça-Junior FJB, Damasceno BPGDL, Converti A, de Lima ÁAN. Chitosan-Based Films with 2-Aminothiophene Derivative: Formulation, Characterization and Potential Antifungal Activity. Mar Drugs 2022; 20:103. [PMID: 35200633 PMCID: PMC8878255 DOI: 10.3390/md20020103] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2021] [Revised: 01/13/2022] [Accepted: 01/21/2022] [Indexed: 02/04/2023] Open
Abstract
In this study, films of chitosan and 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitrile (6CN), a 2-aminothiophene derivative with great pharmacological potential, were prepared as a system for a topical formulation. 6CN-chitosan films were characterized by physicochemical analyses, such as Fourier-transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), X-ray diffraction (XRD), and scanning electronic microscopy (SEM). Additionally, the antifungal potential of the films was evaluated in vitro against three species of Candida (C. albicans, C. tropicalis, and C. parapsilosis). The results of the FTIR and thermal analysis showed the incorporation of 6CN in the polymer matrix. In the diffractogram, the 6CN-chitosan films exhibited diffraction halos that were characteristic of amorphous structures, while the micrographs showed that 6CN particles were dispersed in the chitosan matrix, exhibiting pores and cracks on the film surface. In addition, the results of antifungal investigation demonstrated that 6CN-chitosan films were effective against Candida species showing potential for application as a new antifungal drug.
Collapse
Affiliation(s)
- Verônica da Silva Oliveira
- Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, RN, Brazil; (V.d.S.O.); (M.M.d.C.); (G.S.B.); (N.E.S.e.S.); (F.H.A.N.); (G.M.C.)
| | - Meriângela Miranda da Cruz
- Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, RN, Brazil; (V.d.S.O.); (M.M.d.C.); (G.S.B.); (N.E.S.e.S.); (F.H.A.N.); (G.M.C.)
| | - Gabriela Suassuna Bezerra
- Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, RN, Brazil; (V.d.S.O.); (M.M.d.C.); (G.S.B.); (N.E.S.e.S.); (F.H.A.N.); (G.M.C.)
| | - Natan Emanuell Sobral e Silva
- Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, RN, Brazil; (V.d.S.O.); (M.M.d.C.); (G.S.B.); (N.E.S.e.S.); (F.H.A.N.); (G.M.C.)
| | - Fernando Henrique Andrade Nogueira
- Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, RN, Brazil; (V.d.S.O.); (M.M.d.C.); (G.S.B.); (N.E.S.e.S.); (F.H.A.N.); (G.M.C.)
| | - Guilherme Maranhão Chaves
- Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, RN, Brazil; (V.d.S.O.); (M.M.d.C.); (G.S.B.); (N.E.S.e.S.); (F.H.A.N.); (G.M.C.)
| | | | | | | | - Attilio Converti
- Department of Civil, Chemical and Environment Engineering, Pole of Chemical Engineering, University of Genoa, I-16145 Genoa, Italy
| | - Ádley Antonini Neves de Lima
- Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, RN, Brazil; (V.d.S.O.); (M.M.d.C.); (G.S.B.); (N.E.S.e.S.); (F.H.A.N.); (G.M.C.)
| |
Collapse
|
4
|
Lima SGM, Freire MCLC, Oliveira VDS, Solisio C, Converti A, de Lima ÁAN. Astaxanthin Delivery Systems for Skin Application: A Review. Mar Drugs 2021; 19:md19090511. [PMID: 34564173 PMCID: PMC8471810 DOI: 10.3390/md19090511] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2021] [Revised: 08/31/2021] [Accepted: 09/01/2021] [Indexed: 12/03/2022] Open
Abstract
Astaxanthin (AST) is a biomolecule known for its powerful antioxidant effect, which is considered of great importance in biochemical research and has great potential for application in cosmetics, as well as food products that are beneficial to human health and medicines. Unfortunately, its poor solubility in water, chemical instability, and low oral bioavailability make its applications in the cosmetic and pharmaceutical field a major challenge for the development of new products. To favor the search for alternatives to enhance and make possible the use of AST in formulations, this article aimed to review the scientific data on its application in delivery systems. The search was made in databases without time restriction, using keywords such as astaxanthin, delivery systems, skin, cosmetic, topical, and dermal. All delivery systems found, such as liposomes, particulate systems, inclusion complexes, emulsions, and films, presented peculiar advantages able to enhance AST properties, among which are stability, antioxidant potential, biological activities, and drug release. This survey showed that further studies are needed for the industrial development of new AST-containing cosmetics and topical formulations.
Collapse
Affiliation(s)
| | | | - Verônica da Silva Oliveira
- Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, RN, Brazil; (S.G.M.L.); (V.d.S.O.)
| | - Carlo Solisio
- Department of Civil, Chemical and Environment Engineering, Pole of Chemical Engineering, University of Genoa, I-16145 Genoa, Italy; (C.S.); (A.C.)
| | - Attilio Converti
- Department of Civil, Chemical and Environment Engineering, Pole of Chemical Engineering, University of Genoa, I-16145 Genoa, Italy; (C.S.); (A.C.)
| | - Ádley Antonini Neves de Lima
- Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, RN, Brazil; (S.G.M.L.); (V.d.S.O.)
- Correspondence: ; Tel.: +55-(84)99928-8864
| |
Collapse
|
5
|
Risperidone/Randomly Methylated β-Cyclodextrin Inclusion Complex-Compatibility Study with Pharmaceutical Excipients. Molecules 2021; 26:molecules26061690. [PMID: 33802960 PMCID: PMC8002621 DOI: 10.3390/molecules26061690] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2021] [Revised: 03/12/2021] [Accepted: 03/15/2021] [Indexed: 11/16/2022] Open
Abstract
Risperidone (RSP) is an atypical antipsychotic drug used in treating schizophrenia, behavioral, and psychological symptoms of dementia and irritability associated with autism. The drug substance is practically insoluble in water and exhibits high lipophilicity. It also presents incompatibilities with pharmaceutical excipients such as magnesium stearate, lactose, and cellulose microcrystalline. RSP encapsulation by randomly methylated β-cyclodextrin (RM-β-CD) was performed in order to enhance drug solubility and stability and improve its biopharmaceutical profile. The inclusion complex formation was evaluated using thermal methods, powder X-ray diffractometry (PXRD), universal-attenuated total reflectance Fourier transform infrared (UATR-FTIR), UV spectroscopy, and saturation solubility studies. The 1:1 stoichiometry ratio and the apparent stability constant of the inclusion complex were determined by means of the phase solubility method. The compatibility between the supramolecular adduct and pharmaceutical excipients starch, anhydrous lactose, magnesium stearate, and cellulose microcrystalline was studied employing thermoanalytical tools (TG-thermogravimetry/DTG-derivative thermogravimetry/HF-heat flow) and spectroscopic techniques (UATR-FTIR, PXRD). The compatibility study reveals that there are no interactions between the supramolecular adduct with starch, magnesium stearate, and cellulose microcrystalline, while incompatibility with anhydrous lactose is observed even under ambient conditions. The supramolecular adduct of RSP with RM-β-CD represents a valuable candidate for further research in developing new formulations with enhanced bioavailability and stability, and the results of this study allow a pertinent selection of three excipients that can be incorporated in solid dosage forms.
Collapse
|
6
|
Encapsulation of Risperidone by Methylated β-Cyclodextrins: Physicochemical and Molecular Modeling Studies. Molecules 2020; 25:molecules25235694. [PMID: 33287127 PMCID: PMC7730204 DOI: 10.3390/molecules25235694] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2020] [Revised: 11/28/2020] [Accepted: 12/01/2020] [Indexed: 12/15/2022] Open
Abstract
Risperidone (RSP) is an atypical antipsychotic drug which acts as a potent antagonist of serotonin-2 (5TH2) and dopamine-2 (D2) receptors in the brain; it is used to treat schizophrenia, behavioral and psychological symptoms of dementia and irritability associated with autism. It is a poorly water soluble benzoxazole derivative with high lipophilicity. Supramolecular adducts between drug substance and two methylated β-cyclodextrins, namely heptakis(2,6-di-O-methyl)-β-cyclodextrin (DM-β-CD) and heptakis(2,3,6-tri-O-methyl)-β-cyclodextrin (TM-β-CD) were obtained in order to enhance RSP solubility and improve its biopharmaceutical profile. The inclusion complexes were evaluated by means of thermoanalytical methods (TG—thermogravimetry/DTG—derivative thermogravimetry/HF—heat flow), powder X-ray diffractometry (PXRD), universal-attenuated total reflectance Fourier transform infrared (UATR-FTIR), UV spectroscopy and saturation solubility studies. Job’s method was employed for the determination of the stoichiometry of the inclusion complexes, which was found to be 2:1 for both guest–host systems. Molecular modeling studies were carried out for an in-depth characterization of the interaction between drug substance and cyclodextrins (CDs). The physicochemical properties of the supramolecular systems differ from those of RSP, demonstrating the inclusion complex formation between drug and CDs. The RSP solubility was enhanced as a result of drug encapsulation in the CDs cavity, the higher increase being obtained with DM-β-CD as host; the guest–host system RSP/DM-β-CD can thus be a starting point for further research in developing new formulations containing RSP, with enhanced bioavailability.
Collapse
|
7
|
Marques CSF, Barreto NS, de Oliveira SSC, Santos ALS, Branquinha MH, de Sousa DP, Castro M, Andrade LN, Pereira MM, da Silva CF, Chaud MV, Jain S, Fricks AT, Souto EB, Severino P. β-Cyclodextrin/Isopentyl Caffeate Inclusion Complex: Synthesis, Characterization and Antileishmanial Activity. Molecules 2020; 25:E4181. [PMID: 32932660 PMCID: PMC7570699 DOI: 10.3390/molecules25184181] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2020] [Revised: 09/04/2020] [Accepted: 09/09/2020] [Indexed: 11/16/2022] Open
Abstract
Isopentyl caffeate (ICaf) is a bioactive ester widely distributed in nature. Our patented work has shown promising results of this molecule against Leishmania. However, ICaf shows poor solubility, which limits its usage in clinical settings. In this work, we have proposed the development of an inclusion complex of ICaf in β-cyclodextrin (β-CD), with the aim to improve the drug solubility, and thus, its bioavailability. The inclusion complex (ICaf:β-CD) was developed applying three distinct methods, i.e., physical mixture (PM), kneading (KN) or co-evaporation (CO) in different molar proportions (0.25:1, 1:1 and 2:1). Characterization of the complexes was carried out by thermal analysis, Fourier-transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM) and molecular docking. The ICaf:β-CD complex in a molar ratio of 1:1 obtained by CO showed the best complexation and, therefore, was selected for further analysis. Solubility assay showed a marked improvement in the ICaf:β-CD (CO, 1:1) solubility profile when compared to the pure ICaf compound. Cell proliferation assay using ICaf:β-CD complex showed an IC50 of 3.8 and 2.7 µg/mL against L. amazonesis and L. chagasi promastigotes, respectively. These results demonstrate the great potential of the inclusion complex to improve the treatment options for visceral and cutaneous leishmaniases.
Collapse
Affiliation(s)
- Carine S. F. Marques
- Postgraduation in Biotechnology Program, Industrial and Institute of Technology and Research (ITP), Tiradentes University (UNIT), Av. Murilo Dantas, 300, 49010-390 Aracaju, Brazil; (C.S.F.M.); (N.S.B.); (S.J.); (A.T.F.)
| | - Nathalia S. Barreto
- Postgraduation in Biotechnology Program, Industrial and Institute of Technology and Research (ITP), Tiradentes University (UNIT), Av. Murilo Dantas, 300, 49010-390 Aracaju, Brazil; (C.S.F.M.); (N.S.B.); (S.J.); (A.T.F.)
| | - Simone S. C. de Oliveira
- Departament of General Microbiology, Institute of Microbiology Paulo de Góes, Federal University l Rio de Janeiro, 21941-918 Rio de Janeiro, RJ, Brazil; (S.S.C.d.O.); (A.L.S.S.); (M.H.B.)
| | - André L. S. Santos
- Departament of General Microbiology, Institute of Microbiology Paulo de Góes, Federal University l Rio de Janeiro, 21941-918 Rio de Janeiro, RJ, Brazil; (S.S.C.d.O.); (A.L.S.S.); (M.H.B.)
| | - Marta H. Branquinha
- Departament of General Microbiology, Institute of Microbiology Paulo de Góes, Federal University l Rio de Janeiro, 21941-918 Rio de Janeiro, RJ, Brazil; (S.S.C.d.O.); (A.L.S.S.); (M.H.B.)
| | - Damião P. de Sousa
- Department of Pharmaceutical Sciences, Federal University of Paraíba, 58051-900 Paraíba, Brazil; (D.P.d.S.); (M.C.)
| | - Mayara Castro
- Department of Pharmaceutical Sciences, Federal University of Paraíba, 58051-900 Paraíba, Brazil; (D.P.d.S.); (M.C.)
| | - Luciana N. Andrade
- Department of Medicine, Federal University of Sergipe, CEP 49400-000 Lagarto, Sergipe, Brazil;
| | - Matheus M. Pereira
- CICECO-Aveiro Institute of Materials, Departamento f Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal;
| | - Classius F. da Silva
- Department of Exact Sciences and Earth, Federal University of São Paulo (UNIFESP), 09972-270 Diadema CEP, Brazil;
| | - Marco V. Chaud
- Department of Technological and Environmental Processes, Sorocaba University (UNISO), Rod. Raposo Tavares, Km 92.5, 18023-000 Sorocaba, Brazil;
| | - Sona Jain
- Postgraduation in Biotechnology Program, Industrial and Institute of Technology and Research (ITP), Tiradentes University (UNIT), Av. Murilo Dantas, 300, 49010-390 Aracaju, Brazil; (C.S.F.M.); (N.S.B.); (S.J.); (A.T.F.)
| | - Alini T. Fricks
- Postgraduation in Biotechnology Program, Industrial and Institute of Technology and Research (ITP), Tiradentes University (UNIT), Av. Murilo Dantas, 300, 49010-390 Aracaju, Brazil; (C.S.F.M.); (N.S.B.); (S.J.); (A.T.F.)
| | - Eliana B. Souto
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciênciasda Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
- CEB-Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal
| | - Patricia Severino
- Postgraduation in Biotechnology Program, Industrial and Institute of Technology and Research (ITP), Tiradentes University (UNIT), Av. Murilo Dantas, 300, 49010-390 Aracaju, Brazil; (C.S.F.M.); (N.S.B.); (S.J.); (A.T.F.)
- Center for Biomedical Engineering, Department of Medicine, Brigham and Women′s Hospital, Harvard Medical School, 65 Landsdowne Street, Cambridge, MA 02139, USA
- Tiradentes Institute, 150 Mt Vernon St, Dorchester, MA 02125, USA
| |
Collapse
|
8
|
Bardasov IN, Alekseeva AY, Ershov OV, Mar’yasov MA. Antiproliferative Activity of N-Substituted 2,4-Diamino-5-Aryl-5,6,7,8,9,10-Hexahydrobenzo[B][1,8]Naphthyridine-3-Carbonitriles. Pharm Chem J 2020. [DOI: 10.1007/s11094-020-02236-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
9
|
de Almeida Magalhães TSS, de Oliveira Macedo PC, Kawashima Pacheco SY, da Silva SS, Barbosa EG, Pereira RR, Costa RMR, Silva Junior JOC, da Silva Ferreira MA, de Almeida JC, Rolim Neto PJ, Converti A, Neves de Lima ÁA. Development and Evaluation of Antimicrobial and Modulatory Activity of Inclusion Complex of Euterpe oleracea Mart Oil and β-Cyclodextrin or HP-β-Cyclodextrin. Int J Mol Sci 2020; 21:E942. [PMID: 32023867 PMCID: PMC7037319 DOI: 10.3390/ijms21030942] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2019] [Revised: 12/23/2019] [Accepted: 01/09/2020] [Indexed: 12/15/2022] Open
Abstract
The development of inclusion complexes is used to encapsulate nonpolar compounds and improve their physicochemical characteristics. This study aims to develop complexes made up of Euterpe oleracea Mart oil (EOO) and β-cyclodextrin (β-CD) or hydroxypropyl-β-cyclodextrin (HP-β-CD) by either kneading (KND) or slurry (SL). Complexes were analyzed by molecular modeling, Fourier-transform infrared spectroscopy, scanning electron microscopy, powder X-ray diffraction, thermogravimetry analysis and differential scanning calorimetry. The antibacterial activity was expressed as Minimum Inhibitory Concentration (MIC), and the antibiotic resistance modulatory activity as subinhibitory concentration (MIC/8) against Escherichia coli, Streptomyces aureus, Pseudomonas aeruginosa and Enterococcus faecalis. Inclusion complexes with β-CD and HP-β-CD were confirmed, and efficiency was proven by an interaction energy between oleic acid and β-CD of -41.28 ± 0.57 kJ/mol. MIC values revealed higher antibacterial activity of complexes compared to the isolated oil. The modulatory response of EOO and EOO-β-CD prepared by KND as well as of EOO-β-CD and EOO-HP-β-CD prepared by SL showed a synergistic effect with ampicillin against E. coli, whereas it was not significant with the other drugs tested, maintaining the biological response of antibiotics. The antimicrobial response exhibited by the complexes is of great significance because it subsidizes studies for the development of new pharmaceutical forms.
Collapse
Affiliation(s)
- Thalita Sévia Soares de Almeida Magalhães
- Department of Pharmacy, Laboratório Escola de Farmácia Industrial, Federal University of Rio Grande do Norte, Natal, RN 59012-570, Brazil; (T.S.S.d.A.M.); (P.C.d.O.M.); (S.Y.K.P.)
| | - Pollyana Cristina de Oliveira Macedo
- Department of Pharmacy, Laboratório Escola de Farmácia Industrial, Federal University of Rio Grande do Norte, Natal, RN 59012-570, Brazil; (T.S.S.d.A.M.); (P.C.d.O.M.); (S.Y.K.P.)
| | - Stephany Yumi Kawashima Pacheco
- Department of Pharmacy, Laboratório Escola de Farmácia Industrial, Federal University of Rio Grande do Norte, Natal, RN 59012-570, Brazil; (T.S.S.d.A.M.); (P.C.d.O.M.); (S.Y.K.P.)
| | - Sofia Santos da Silva
- Department of Pharmacy, Laboratório de Química Farmacêutica Computacional, Federal University of Rio Grande do Norte, Natal, RN 59012-570, Brazil; (S.S.d.S.); (E.G.B.)
| | - Euzébio Guimarães Barbosa
- Department of Pharmacy, Laboratório de Química Farmacêutica Computacional, Federal University of Rio Grande do Norte, Natal, RN 59012-570, Brazil; (S.S.d.S.); (E.G.B.)
| | - Rayanne Rocha Pereira
- Department of Pharmacy, Laboratório de Pesquisa e Desenvolvimento Farmacêutico e Cosmético, Federal University of Pará, Pará, PA 66075110, Brazil; (R.R.P.); (R.M.R.C.); (J.O.C.S.J.)
| | - Roseane Maria Ribeiro Costa
- Department of Pharmacy, Laboratório de Pesquisa e Desenvolvimento Farmacêutico e Cosmético, Federal University of Pará, Pará, PA 66075110, Brazil; (R.R.P.); (R.M.R.C.); (J.O.C.S.J.)
| | - José Otávio Carréra Silva Junior
- Department of Pharmacy, Laboratório de Pesquisa e Desenvolvimento Farmacêutico e Cosmético, Federal University of Pará, Pará, PA 66075110, Brazil; (R.R.P.); (R.M.R.C.); (J.O.C.S.J.)
| | - Marília Andreza da Silva Ferreira
- Department of Nursing, Laboratorio de Microbiologia, Parasitologia and Patologia, Federal University of Campina Grande, Paraíba, PB 58900000, Brazil; (M.A.d.S.F.); (J.C.d.A.)
| | - José Cezário de Almeida
- Department of Nursing, Laboratorio de Microbiologia, Parasitologia and Patologia, Federal University of Campina Grande, Paraíba, PB 58900000, Brazil; (M.A.d.S.F.); (J.C.d.A.)
| | - Pedro José Rolim Neto
- Department of Pharmacy, Laboratory of Medical Technology, Federal University of Pernambuco, Recife, PE 50740-521, Brazil;
| | - Attilio Converti
- Dipartimento of Civil, Chemical and Environmental Engineering, Pole of Chemical Engineering, Genoa University, I-16145 Genoa, Italy;
| | - Ádley Antonini Neves de Lima
- Department of Pharmacy, Laboratório Escola de Farmácia Industrial, Federal University of Rio Grande do Norte, Natal, RN 59012-570, Brazil; (T.S.S.d.A.M.); (P.C.d.O.M.); (S.Y.K.P.)
| |
Collapse
|
10
|
Song S, Gao K, Niu R, Wang J, Zhang J, Gao C, Yang B, Liao X. Inclusion complexes between chrysin and amino-appended β-cyclodextrins (ACDs): Binding behavior, water solubility, in vitro antioxidant activity and cytotoxicity. MATERIALS SCIENCE & ENGINEERING. C, MATERIALS FOR BIOLOGICAL APPLICATIONS 2019; 106:110161. [PMID: 31753384 DOI: 10.1016/j.msec.2019.110161] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/08/2019] [Revised: 08/12/2019] [Accepted: 09/03/2019] [Indexed: 10/26/2022]
Abstract
Solid inclusion complexes between chrysin and four amino-appended β-cyclodextrins (ACDs) were prepared by suspension method and characterized in solid and solution states by kinds of analytical methods. The scanning electron microscopy (SEM) showed distinct micro-morphologies of them. Thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC) analysis revealed their unique thermal properties, such as decomposition temperatures and endothermic points. Powder X-ray diffractometry (XRD) analysis disclosed their unique crystal patterns. Their nuclear magnetic resonance (NMR) analyses provided the variations of chemical shifts before and after the formation of inclusion complexes. Their binding stability constants (Ks) were 574, 842, 704, and 474 L·mol-1, respectively, as determined by spectral titration. A 1:1 inclusion mode with self-assembly of their amino side chains inside the ACD cavity was proposed based on Job plot and 2D-ROESY experiments. Water solubility of chrysin was promoted up to 4411.98 μg·mL-1 after formation of inclusion complexes with ACDs, better than that of β-CD and its derivatives, i.e., HP- and SBE-β-CD. In vitro antioxidant activity of chrysin was also improved after inclusion complexation by the DPPH scavenging assay. Furthermore, in vitro cytotoxicity of solid inclusion complexes towards three human cancer cell lines, A549, HT-29 and HCT116 were enhanced significantly.
Collapse
Affiliation(s)
- Shuang Song
- Faculty of Life Science and Technology, Kunming University of Science and Technology, 650500 Kunming, China
| | - Kai Gao
- Faculty of Life Science and Technology, Kunming University of Science and Technology, 650500 Kunming, China
| | - Raomei Niu
- Faculty of Life Science and Technology, Kunming University of Science and Technology, 650500 Kunming, China; Jiangsu Xinchen Pharmaceutical Co., LTD, 222047 Lianyungang, China
| | - Jin Wang
- School of Pharmacy, Jiangsu Key Laboratory for Bioresources of Saline Soils, Yancheng Teachers University, 224007 Yancheng, China
| | - Jihong Zhang
- Faculty of Medicine, Kunming University of Science and Technology, Kunming 650500, China; Research Centre for Pharmaceutical Care and Quality Management, First People's Hospital of Yunnan Province, Kunming 650500, China
| | - Chuanzhu Gao
- Faculty of Life Science and Technology, Kunming University of Science and Technology, 650500 Kunming, China
| | - Bo Yang
- Faculty of Life Science and Technology, Kunming University of Science and Technology, 650500 Kunming, China
| | - Xiali Liao
- Faculty of Life Science and Technology, Kunming University of Science and Technology, 650500 Kunming, China.
| |
Collapse
|